Cardiac Sarcoidosis Randomized Trial
Prospective randomized controlled trial comparing low dose Prednisone(or Prednisolone)/Methotrexate combination to standard dose Prednisone(or Prednisolone) in patients diagnosed with acute active cli...
Efficacy and Safety Study of OATD-01 in Patients With Active Pulmonary Sarcoidosis
This is a Phase 2, randomized, double-blind, placebo-controlled, adaptive, multicenter study to evaluate the efficacy, safety, tolerability, Pharmacodynamics (PD), and Pharmacokinetics (PK) of OATD-01...
A Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis
A phase 1b/2 study of XTMAB-16 in patients with pulmonary sarcoidosis...
Rilonacept in Subjects With Cardiac Sarcoidosis
The primary objective of this study is to evaluate the effect of rilonacept, added to standard therapy and compared with standard therapy alone, on improvement in myocardial inflammation in subjects w...
A Phase 2 Study of the Safety and Efficacy of Brepocitinib in Adults With Cutaneous Sarcoidosis (BEACON)
This study will evaluate the clinical safety and efficacy of oral brepocitinib in participants with cutaneous sarcoidosis....
Top Cities for Sarcoidosis Clinical Trials
Sarcoidosis clinical trials are recruiting across 30 cities. Here are the cities with the most active studies:
About Sarcoidosis
Sarcoidosis is an inflammatory disease characterized by the formation of granulomas (clumps of inflammatory cells) in various organs, most commonly the lungs and lymph nodes. Many cases resolve on their own, but some require treatment with corticosteroids or immunosuppressive medications.
Clinical trials are advancing new treatments for sarcoidosis. Currently, 5 studies are recruiting a combined 472 participants across the United States. Research is being conducted by 5 organizations including Ottawa Heart Institute Research Corporation, Molecure S.A., Xentria, Inc. and 2 others.
2026 Sarcoidosis Research Landscape
As of March 2026, the sarcoidosis clinical trial landscape includes 5 actively recruiting studies across 30 cities in the United States. These studies are collectively seeking 472 participants, with an average enrollment target of 94 per study.
Research is being led by 5 different organizations, including Ottawa Heart Institute Research Corporation, Molecure S.A., Xentria, Inc., Mayo Clinic, Priovant Therapeutics, Inc..
Geographically, sarcoidosis trials are most concentrated in Baltimore, Maryland (3 trials); Birmingham, Alabama (2 trials); Rochester, Minnesota (2 trials); Philadelphia, Pennsylvania (2 trials); Chicago, Illinois (2 trials) and 7 other cities.
Featured Sarcoidosis Studies
Highlighted recruiting studies for sarcoidosis, selected by enrollment size and research scope.
Cardiac Sarcoidosis Randomized Trial
Prospective randomized controlled trial comparing low dose Prednisone(or Prednisolone)/Methotrexate combination to standard dose Prednisone(or Prednisolone) in patients diagnosed with acute active clinically manifest cardiac sarcoidosis and not yet treated. The Investigators hypothesize that low dose Prednisone(or Prednisolone)/Methotrexate combination will be as effective as standard dose Predni...
Efficacy and Safety Study of OATD-01 in Patients With Active Pulmonary Sarcoidosis
This is a Phase 2, randomized, double-blind, placebo-controlled, adaptive, multicenter study to evaluate the efficacy, safety, tolerability, Pharmacodynamics (PD), and Pharmacokinetics (PK) of OATD-01 in the treatment of subjects with active pulmonary sarcoidosis.
A Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis
A phase 1b/2 study of XTMAB-16 in patients with pulmonary sarcoidosis
Frequently Asked Questions About Sarcoidosis Clinical Trials
Are there sarcoidosis clinical trials near me?
Yes, there are 5 sarcoidosis clinical trials currently recruiting across 30+ cities in the United States, including Baltimore, Maryland; Birmingham, Alabama; Rochester, Minnesota. Browse the studies above to find one at a location convenient for you.
How do I join a sarcoidosis clinical trial?
To join a sarcoidosis clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are sarcoidosis clinical trials free?
Yes, participation in sarcoidosis clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of sarcoidosis treatments are being studied?
Current sarcoidosis clinical trials are testing a range of approaches. These include new drugs, combination therapies, medical devices, and other interventions sponsored by 5 research organizations.
Is it safe to participate in sarcoidosis clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated March 1, 2026 from ClinicalTrials.gov
About This Data
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated March 1, 2026 · Data from ClinicalTrials.gov